# Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer

> **NCT00954525** · PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 14 (actual)

## Conditions studied

- Metastatic Pancreatic Cancer

## Interventions

- **DRUG:** Gemcitabine and Erlotinib
- **DIETARY_SUPPLEMENT:** Intravenous Vitamin C

## Key facts

- **NCT ID:** NCT00954525
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00954525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00954525, "Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00954525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*